In cancer therapy, higher levels of Nrf2 with the upregulated antioxidant pathway lead to cancer cells acquiring protection from the cytotoxic effects of the chemotherapeutic drugs and the development of chemoresistance. This evidence concerns the gene NFE2L2 and cancer.